Amwell (AMWL) Announces Launch of 11.28M Share Proposed Public Offering

Amwell® (NYSE: AMWL), a national telehealth leader, today announced that it has commenced the roadshow for a proposed public offering. Amwell has filed a registration statement with the Securities and Exchange Commission (“SEC”) for certain selling stockholders (the “Selling Stockholders”) to offer 11,280,647 shares of Amwell’s Class A common stock to the public. In addition, the Selling Stockholders intend to grant the underwriters a 30-day option to purchase up to 1,692,097 additional shares of Class A common stock at the public offering price, less underwriting discounts and commissions. Amwell will not receive any proceeds from this offering.

Morgan Stanley, Goldman Sachs & Co. LLC, Piper Sandler and UBS Investment Bank are acting as lead joint book-running managers for the proposed offering. Credit Suisse, Cowen and Berenberg are acting as bookrunners for the proposed offering.

You May Also Be Interested In

• Manulife prices $750M subordinated notes offering at 6.146%
• Hyperscale Data ends Bitcoin mining to prep Michigan AI data center
• Polaryx Therapeutics names Will Charlton as chief medical officer